Bio-Rad Laboratories Total Current Liabilities 2010-2024 | BIO
Bio-Rad Laboratories total current liabilities from 2010 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
- Bio-Rad Laboratories total current liabilities for the quarter ending September 30, 2024 were $0.487B, a 16.33% decline year-over-year.
- Bio-Rad Laboratories total current liabilities for 2023 were $0.523B, a 8.07% decline from 2022.
- Bio-Rad Laboratories total current liabilities for 2022 were $0.569B, a 16.48% decline from 2021.
- Bio-Rad Laboratories total current liabilities for 2021 were $0.681B, a 7.82% increase from 2020.
| Bio-Rad Laboratories Annual Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2023 | $523 |
| 2022 | $569 |
| 2021 | $681 |
| 2020 | $632 |
| 2019 | $905 |
| 2018 | $451 |
| 2017 | $503 |
| 2016 | $471 |
| 2015 | $441 |
| 2014 | $447 |
| 2013 | $487 |
| 2012 | $472 |
| 2011 | $459 |
| 2010 | $667 |
| 2009 | $420 |
| Bio-Rad Laboratories Quarterly Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2024-06-30 | $487 |
| 2024-03-31 | $466 |
| 2023-12-31 | $523 |
| 2023-09-30 | $558 |
| 2023-06-30 | $582 |
| 2023-03-31 | $590 |
| 2022-12-31 | $569 |
| 2022-09-30 | $571 |
| 2022-06-30 | $614 |
| 2022-03-31 | $648 |
| 2021-12-31 | $681 |
| 2021-09-30 | $650 |
| 2021-06-30 | $587 |
| 2021-03-31 | $610 |
| 2020-12-31 | $632 |
| 2020-09-30 | $987 |
| 2020-06-30 | $927 |
| 2020-03-31 | $869 |
| 2019-12-31 | $905 |
| 2019-09-30 | $434 |
| 2019-06-30 | $446 |
| 2019-03-31 | $444 |
| 2018-12-31 | $451 |
| 2018-09-30 | $453 |
| 2018-06-30 | $442 |
| 2018-03-31 | $456 |
| 2017-12-31 | $503 |
| 2017-09-30 | $466 |
| 2017-06-30 | $455 |
| 2017-03-31 | $408 |
| 2016-12-31 | $471 |
| 2016-09-30 | $443 |
| 2016-06-30 | $410 |
| 2016-03-31 | $401 |
| 2015-12-31 | $441 |
| 2015-09-30 | $435 |
| 2015-06-30 | $404 |
| 2015-03-31 | $417 |
| 2014-12-31 | $447 |
| 2014-09-30 | $504 |
| 2014-06-30 | $480 |
| 2014-03-31 | $481 |
| 2013-12-31 | $487 |
| 2013-09-30 | $463 |
| 2013-06-30 | $431 |
| 2013-03-31 | $447 |
| 2012-12-31 | $472 |
| 2012-09-30 | $434 |
| 2012-06-30 | $417 |
| 2012-03-31 | $444 |
| 2011-12-31 | $459 |
| 2011-09-30 | $415 |
| 2011-06-30 | $443 |
| 2011-03-31 | $428 |
| 2010-12-31 | $667 |
| 2010-09-30 | $411 |
| 2010-06-30 | $389 |
| 2010-03-31 | $398 |
| 2009-12-31 | $420 |
| 2009-09-30 | $416 |
| 2009-06-30 | $384 |
| 2009-03-31 | $356 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $10.338B | $2.671B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $202.220B | 25.79 |
| Stryker (SYK) | United States | $143.322B | 32.30 |
| Boston Scientific (BSX) | United States | $130.065B | 37.39 |
| Medtronic (MDT) | Ireland | $112.498B | 16.74 |
| EssilorLuxottica (ESLOY) | France | $111.686B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.423B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.501B | 28.26 |
| GE HealthCare Technologies (GEHC) | United States | $39.264B | 20.36 |
| ResMed (RMD) | United States | $37.048B | 30.44 |
| Terumo (TRUMY) | Japan | $29.575B | 41.77 |
| Koninklijke Philips (PHG) | Netherlands | $25.012B | 19.14 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.536B | 13.71 |
| Insulet (PODD) | United States | $18.791B | 74.86 |
| Baxter (BAX) | United States | $17.673B | 11.51 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.619B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.136B | 38.63 |
| Demant (WILYY) | Denmark | $8.351B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.084B | 14.14 |
| Haemonetics (HAE) | United States | $4.474B | 21.43 |
| TG Therapeutics (TGTX) | United States | $4.460B | 0.00 |
| ICU Medical (ICUI) | United States | $4.318B | 41.21 |
| Prestige Consumer Healthcare (PBH) | United States | $3.983B | 19.75 |
| Perrigo (PRGO) | Ireland | $3.596B | 10.59 |
| Neogen (NEOG) | United States | $3.517B | 40.57 |
| Envista Holdings (NVST) | United States | $3.509B | 26.14 |
| Agios Pharmaceuticals (AGIO) | United States | $3.368B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $3.041B | 19.50 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.942B | 18.94 |
| LeMaitre Vascular (LMAT) | United States | $2.342B | 56.97 |
| Warby Parker (WRBY) | United States | $1.964B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.888B | 33.04 |
| AtriCure (ATRC) | United States | $1.826B | 0.00 |
| InMode (INMD) | Israel | $1.630B | 9.80 |
| Curaleaf Holdings (CURLF) | Canada | $1.384B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.357B | 9.70 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.280B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.206B | 0.00 |
| Owens & Minor (OMI) | United States | $0.995B | 7.77 |
| Phibro Animal Health (PAHC) | United States | $0.966B | 17.04 |
| CeriBell (CBLL) | United States | $0.962B | 0.00 |
| National Vision Holdings (EYE) | United States | $0.906B | 30.29 |
| Capricor Therapeutics (CAPR) | United States | $0.895B | 0.00 |
| Evolus (EOLS) | United States | $0.866B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.691B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.605B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.582B | 17.56 |
| Quanterix (QTRX) | United States | $0.580B | 0.00 |
| Surmodics (SRDX) | United States | $0.549B | 0.00 |
| Valneva SE (VALN) | France | $0.426B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.398B | 0.00 |
| ZimVie (ZIMV) | United States | $0.393B | 33.12 |
| Viemed Healthcare (VMD) | United States | $0.353B | 33.59 |
| Cerus (CERS) | United States | $0.331B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.320B | 21.45 |
| Sanara MedTech (SMTI) | United States | $0.308B | 0.00 |
| Biote (BTMD) | United States | $0.301B | 13.90 |
| Zynex (ZYXI) | United States | $0.287B | 60.07 |
| Jin Medical (ZJYL) | China | $0.284B | 0.00 |
| MacroGenics (MGNX) | United States | $0.273B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.269B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.264B | 0.00 |
| Omeros (OMER) | United States | $0.256B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.236B | 15.90 |
| High Tide (HITI) | Canada | $0.221B | 91.67 |
| Brainsway (BWAY) | Israel | $0.181B | 217.20 |
| Organigram Holdings (OGI) | Canada | $0.172B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.151B | 20.39 |
| Rockwell Medical (RMTI) | United States | $0.137B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.129B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.116B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.111B | 0.00 |
| Veru (VERU) | United States | $0.107B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.104B | 0.00 |
| Fonar (FONR) | United States | $0.095B | 9.82 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 23.10 |
| Cellectar Biosciences (CLRB) | United States | $0.086B | 0.00 |
| Sanuwave Health (SNWVD) | United States | $0.079B | 2.67 |
| Modular Medical (MODD) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.070B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.070B | 0.00 |
| MariMed (MRMD) | United States | $0.062B | 0.00 |
| Safety Shot (SHOT) | United States | $0.062B | 0.00 |
| Apyx Medical (APYX) | United States | $0.053B | 0.00 |
| Exagen (XGN) | United States | $0.050B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.048B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.040B | 0.00 |
| ImmuCell (ICCC) | United States | $0.028B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| Nephros (NEPH) | United States | $0.017B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 14.20 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |